Home / Rivastigmine / Sweden
SE ATC N06DA03 · updated 2 Nov 2026
Rivastigmine shortage in Sweden
Is there a Rivastigmine shortage in Sweden?
Yes. As of 2 Nov 2026, 4 Rivastigmine products are reported short in Sweden, the first since 4 May 2026. The company estimate for the return is 15 Nov 2026 (latest 1 Feb 2027). Main reason: not stated.
Also short in United States, Italy, Spain, Austria, Belgium. All countries.
Affected products in Sweden
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| SE | Rivastor 4,6 mg/24 timmar Påse, 90 (3x30) depotplåster | Orion Corporation | 4 May 2026 | 5 Jan 2027 | Not stated |
| SE | Rivastigmine Teva 9,5 mg/24 timmar Påse, 30 plåster | Teva B.V. | 25 Sep 2026 | 15 Nov 2026 | Not stated |
| SE | Nimvastid 1,5 mg Blister, 28 kapslar | Krka d.d., Novo mesto | 25 Oct 2026 | 3 Dec 2026 | Not stated |
| SE | Rivastor 9,5 mg/24 timmar Påse, 90 (3x30) depotplåster anticipated | Orion Corporation | 21 Dec 2026 | 1 Feb 2027 | Not stated |
Source
Läkemedelsverket (Swedish Medical Products Agency). Official list. Ongoing and announced shortages (restanmälningar) reported by companies; one row per pack.